 |
Minimalna wpłata $50 Ekskluzywna promocja |
Nasz wynik |
0% prowizja |
Are you looking to buy Protalix BioTherapeutics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:PLX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Protalix BioTherapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company offers Elelyso, a plant cell expressed recombinant glucocerebrosidase enzyme for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in phase III clinical trials for the treatment of Fabry diseases; OPRX-106, an orally-delivered protein product candidate for the treatment of inflammatory bowel disease, as well as completed Phase IIa clinical trial for ulcerative colitis patients; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; and PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is headquartered in Karmiel, Israel.
Średnia wielkość
254,392 shs
KAPITAŁ RYNKOWY
$186.69 million
Giełda Papierów Wartościowych
NYSEAMERICAN
Proszę kupić te akcje!
|
NAZWA
|
TICKER
|
PRZEMYSŁ
|
SEKTOR
|
VOLUME
|
KUP TERAZ TĘ AKCJĘ
|
|---|---|---|---|---|---|
|
AMEX:PLX
|
Produkty biologiczne, z wyjątkiem diagnostycznych
|
Medyczny
|
36,972 shs
|
Below is a quick guide on how to buy AMEX:PLX stocks safe, fast and around the world in less than five minutes.
Krok 1: Otworzyć rachunek w eToro – eToro is the best broker to buy Protalix BioTherapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Krok 2: Załadować Państwa ID - Zgodnie z przepisami KYC eToro poprosi Państwa o przesłanie kopii paszportu lub prawa jazdy.
Krok 3: Wpłata środków - Proszę wpłacić trochę pieniędzy na swoje nowo utworzone konto eToro. Mogą Państwo wybrać pomiędzy przelewem bankowym, e-wallet lub kartą debetową/kredytową lub Paypal.
Krok 4: Buy Protalix BioTherapeutics – Search for “”AMEX:PLX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Protalix BioTherapeutics stocks with 0% commission!.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
1 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Protalix BioTherapeutics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Protalix BioTherapeutics stock.
Wall Street analysts have given Protalix BioTherapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Protalix BioTherapeutics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
2 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
3 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:PLX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Protalix BioTherapeutics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Protalix BioTherapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Ponieważ eToro jest platformą regulowaną, musi Pan wypełnić proces KYC, jest to standardowa procedura i zajmuje tylko kilka minut. Musi Pan przedstawić dowód tożsamości ze zdjęciem (paszport, prawo jazdy) oraz dowód adresu (rachunek za media, wyciąg z banku).
Po zarejestrowaniu się i zweryfikowaniu konta, należy wpłacić środki. eToro akceptuje karty kredytowe/debetowe, przelewy bankowe, a także e-wallety. Tak więc niezależnie od Państwa preferencji znajdzie się coś dla Państwa.
Now that you’ve funded your eToro account, just type “AMEX:PLX stocks" w pasku wyszukiwania na górze ekranu i nacisnąć "handel".
All that’s left is to buy some AMEX:PLX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:PLX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Protalix BioTherapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Protalix BioTherapeutics is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for Protalix BioTherapeutics.
Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX) issued its quarterly earnings results on Thursday, October, 29th. The company reported ($0.14) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.08) by $0.06. The company had revenue of $10.79 million for the quarter, compared to analysts’ expectations of $13.60 million.
View Protalix BioTherapeutics’ earnings history.
Shares of Protalix BioTherapeutics reverse split on the morning of Friday, December 20th 2019. The 1-10 reverse split was announced on Monday, December 9th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 19th 2019. An investor that had 100 shares of Protalix BioTherapeutics stock prior to the reverse split would have 10 shares after the split.
1 brokers have issued 1-year target prices for Protalix BioTherapeutics’ stock. Their forecasts range from $11.00 to $11.00. On average, they anticipate Protalix BioTherapeutics’ stock price to reach $11.00 in the next year. This suggests a possible upside of 91.3% from the stock’s current price.
View analysts’ price targets for Protalix BioTherapeutics or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:PLX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Ponad 95% środków klientów jest przechowywanych w trybie offline, w zimnym magazynie, co jest kluczowe dla każdego brokera, który zarządza Państwa aktywami. Niezależnie od tego, jak bezpieczna ma być platforma, zalecamy stosowanie 2FA, aby dodać dodatkową warstwę bezpieczeństwa do Państwa konta.
eToro oferuje użytkownikom szereg funkcji, aby mogli Państwo jak najszybciej zacząć inwestować. Mają Państwo stosunkowo unikalną funkcję copy trading, która pozwala na uzyskanie pasywnego dochodu poprzez odzwierciedlanie doświadczonych traderów, co pozwala szybko zacząć zarabiać i daje lepsze zrozumienie strategii stosowanych przez profesjonalistów. Dodatkowo eToro umożliwia użytkownikom inwestowanie w zarządzane portfele, przy czym zarządzany portfel to różne podobne aktywa zgrupowane razem, co pozwala na dywersyfikację konta i zmniejsza ewentualne ryzyko. Dla tych, którzy mają już doświadczenie w handlu, mogą Państwo inwestować na rynkach poza akcjami, ponieważ eToro pozwala użytkownikom na handel ETF-ami, towarami, kryptowalutami i indeksami. Jeżeli już inwestują Państwo poza przestrzenią giełdową, może to być bardzo przydatne, ponieważ pozwala to na zarządzanie wszystkimi Państwa inwestycjami w jednym miejscu.
Protalix BioTherapeutics’ management team includes the following people:
Mr. Dror Bashan, Pres, CEO & Director (Age 54, Pay $404.53k)
Mr. Eyal Rubin M.B.A., Sr. VP, CFO, Treasurer & Corp. Sec. (Age 45, Pay $323.63k)
Mr. Yaron Naos, Sr. VP of Operations (Age 57, Pay $305.87k)
Dr. Einat Brill-Almon, Sr. VP & Chief Devel. Officer (Age 61, Pay $328.26k)
Ms. Dafna Shelly M.Sc., MBA, VP of HR
Some companies that are related to Protalix BioTherapeutics include DBV Technologies (DBVT), SQZ Biotechnologies (SQZ), AVROBIO (AVRO), MeiraGTx (MGTX), Gritstone Oncology (GRTS), Curis (CRIS), Oyster Point Pharma (OYST), Poseida Therapeutics (PSTX), Jounce Therapeutics (JNCE), Fusion Pharmaceuticals (FUSN), Harpoon Therapeutics (HARP), Solid Biosciences (SLDB), Opthea (OPT), Cardiff Oncology (CRDF) and Surface Oncology (SURF).
View all of PLX’s competitors.
CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.
Based on aggregate information from Reportlab, some companies that other Protalix BioTherapeutics investors own include Brainstorm Cell Therapeutics (BCLI), Pluristem Therapeutics (PSTI), Novavax (NVAX), BioLineRx (BLRX), VBI Vaccines (VBIV), Sangamo Therapeutics (SGMO), Verastem (VSTM), OPKO Health (OPK), Sorrento Therapeutics (SRNE) and CRISPR Therapeutics (CRSP).
Protalix BioTherapeutics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “PLX.”
Protalix BioTherapeutics’ stock is owned by many different retail and institutional investors. Top institutional investors include GSA Capital Partners LLP (0.03%).
View institutional ownership trends for Protalix BioTherapeutics.
PLX stock was bought by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP.
View insider buying and selling activity for Protalix BioTherapeutics or or view top insider-buying stocks.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
Shares of PLX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, Przegląd DEGiro, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review i wiele innych. Proszę przeczytać jedną z recenzji, aby dowiedzieć się wszystkiego o brokerze i zacząć kupować akcje już teraz.
One share of PLX stock can currently be purchased for approximately $5.75.
Protalix BioTherapeutics has a market capitalization of $191.69 million and generates $54.69 million in revenue each year. The company earns $-18,280,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis.
Protalix BioTherapeutics employs 196 workers across the globe.
The official website for Protalix BioTherapeutics is www.protalix.com.
Protalix BioTherapeutics is headquartered at 2 Snunit St, Science Park, Pob 455, KARMIEL, 20100, Israel.
Na Reportlab.org chcemy się upewnić, że mają Państwo wszystkie najbardziej istotne informacje na temat kupno akcji. Przynosimy Państwu najlepsze przewodniki po giełdzie z osobistymi opiniami, informacjami uzupełniającymi, opiniami o platformach, how to's i więcej. Chcą Państwo uzyskać inne informacje? Proszę zajrzeć na stronę Akcje OTC, Akcje NASDAQ, Akcje na NYSE, Akcje LON, Akcje FRA, Akcje ETR, Zapasy EPA, Akcje TSX lub Akcje Amex. Szukam bardziej szczegółowych informacji, takich jak 5g zapasy, akcje biotechnologiczne, akcje złota i inne informacje z naszego Reportlab.
How can you buy Protalix BioTherapeutics stock on the internet?
You can easily buy Protalix BioTherapeutics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Inną opcją jest skorzystanie z usług regulowanego brokera, jak np. IC Markets lub Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:PLX stocks in a safe and complete environment to trade in.
Where to buy Protalix BioTherapeutics stock?
You will first want to find a licensed broker that supports AMEX:PLX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:PLX stocks in a safe and complete environment.
Is AMEX:PLX stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:PLX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Protalix BioTherapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:PLX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Protalix BioTherapeutics stock.
How do you trade Protalix BioTherapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Protalix BioTherapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:PLX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Protalix BioTherapeutics stock?
To sell your AMEX:PLX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Protalix BioTherapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:PLX stock.
Stephen wie wiele o produktach finansowych, a w szczególności pasjonuje się rynkami giełdowymi i ich uczestnikami. Mamy nadzieję, że przedstawione informacje będą dla Państwa pomocne. Coś nie jest całkiem jasne? Proszę zostawić swoje pytania lub komentarze na dole strony.
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ |
Newsletter
Najnowsze wiadomości
| |
Nasz wynik |
0% prowizja |
Dane o akcjach i kryptowalutach w czasie rzeczywistym
Powiadomienia, Porady & Nowości
Best Stocks & Crypto Guides
Recenzje brokerów i giełd online
Reportlab Finance jest stroną czysto informacyjną i w żadnym wypadku nie oznacza doradztwa inwestycyjnego. Wszystkie inwestycje niosą ze sobą ryzyko i mogą Państwo stracić wszystkie swoje inwestycje. Proszę nie inwestować pieniędzy, na których utratę nie mogą sobie Państwo pozwolić.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Zjednoczone Królestwo
Copyright © 2022 Reportlab.Finance | Wszystkie prawa zastrzeżone.
